Lipocine Inc

LPCNNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

8.24M

on 2026-06-30, from 5.32M on 2024-03-31 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$50.0M

Agreement of 2024-04-26. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-04 is not read yet.

Cash

8.3 quarters

$23.3M on 2026-06-30 ÷ $2.8M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 6 of its filings are not read yet.